We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

REBN:NASDAQReborn Coffee, Inc. Analysis

Data as of 2026-05-23 - not real-time

$2.21

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Reborn Coffee, Inc. posted an eye‑catching 80% revenue growth year‑over‑year, yet its operating margin sits above 100% in absolute terms because the company is still losing money, reflected in a trailing EPS of –1.44 and a net profit margin of –113%. The balance sheet is strained, with total debt of $6.66 million dwarfing the $2.59 million cash balance and a debt‑to‑equity ratio exceeding 140%, while book value per share is negative. Cash flow metrics are equally concerning, as operating cash flow and free cash flow are both deeply negative, underscoring ongoing liquidity pressure.
On the technical side, the stock trades near its $2 support level and well below the $2.68 resistance, with the 20‑day and 50‑day SMAs sitting above the current price. RSI hovers around the mid‑40s, indicating neutral momentum, but the MACD histogram is negative and the signal line is bearish, suggesting downward pressure. Volume trends are decreasing, volatility is extremely high at nearly 70% over the past month, and beta is well above 1.5, amplifying market swings. The “Extreme Greed” sentiment index may be inflating short‑term enthusiasm, but the fundamentals and risk profile argue for a cautious stance.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish MACD and price below key moving averages
  • Negative earnings and cash flow
  • High debt load relative to cash

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong revenue growth and diversification news
  • Continued cash burn and balance‑sheet weakness
  • Elevated volatility and beta

Long Term

> 3 years
Cautious
Model confidence: 8/10

Key Factors

  • Sustained negative profitability and ROE
  • Potential liquidity constraints given low market cap and volume
  • High sector cyclicality and market risk

Key Metrics & Analysis

Financial Health

Revenue Growth80.50%
Profit Margin-112.93%
ROE-248.52%
ROA-34.54%
Debt/Equity143.25
P/B Ratio-3.8
Op. Cash Flow$-6505426
Free Cash Flow$-4051617

Technical Analysis

TrendBullish
RSI46.7
Support$2.00
Resistance$2.68
MA 20$2.30
MA 50$2.29
MA 200$2.10
MACDBearish
VolumeDecreasing
Fear & Greed Index91.61

Valuation

GradeOvervalued
TypeGrowth

Risk Assessment

Beta1.75
Volatility69.72%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.